Clinical Trials in Baltimore

Showing 5281-5300 of 23,476 trials

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

NCT01088789

The purpose of this study is to evaluate the safety and feasibility of long term boost vaccination of a lethally irradiated, allogenic pancreatic tumor cell vaccine transfected with the granulocyte macrophage colony-stimulating factor (GM-CSF) gene (GVAX Pancreas Vaccine) alone or given in combination with either a single intravenous dose or daily metronomic oral doses of cyclophosphamide for the treatment of patients with surgically resected adenocarcinoma of the pancreas.

Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins71 participantsStarted Apr 2010

Baltimore, Maryland, United States

COMPLETEDNA< 1 mile

DMID 21-0041; Influenza CVD 59000

NCT05666245

The primary objective of EMIT-2 is to use a randomized controlled trial (RCT) design to implement interventions which are known to reduce inhalation (airborne) transmission, so that the contribution of transmission by route of aerosols for influenza may be identified.

Influenza

University of Maryland, Baltimore34 participantsStarted Feb 2023

Baltimore, Maryland, United States • College Park, Maryland, United States

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

DMID 21-0041; Influenza CVD 59000

Find Trials by Condition in Baltimore

Beating Heart Mitral Valve Repair With the HARPOON™ System

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

Eltrombopag for People With Fanconi Anemia

Metabolic Adaptations to High-fat Diet

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

Study of Uterine Prolapse Procedures - Randomized Trial

A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Improving Mobility After Revascularization in Peripheral Artery Disease

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care

A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration